Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 09-1997 | 06-1997 | 03-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,830 | 5,836 | 8,203 | 8,052 | 8,064 |
| Depreciation Amortization | 9,519 | 7,095 | 4,711 | 2,313 | 7,896 |
| Other Working Capital | 6,361 | 13,890 | 15,030 | 8,781 | -22,676 |
| Other Operating Activity | -9,209 | -11,408 | 1,690 | 87 | -46,267 |
| Operating Cash Flow | $18,501 | $15,413 | $29,634 | $19,233 | $-52,983 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30,971 | -22,810 | -13,923 | -6,529 | -29,312 |
| Net Acquisitions | -2,019 | -2,019 | -2,009 | -2,009 | 261,752 |
| Other Investing Activity | -2,915 | -1,429 | -1,108 | -186 | -1,803 |
| Investing Cash Flow | $-35,905 | $-26,258 | $-17,040 | $-8,724 | $230,637 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -11,501 | -8,583 | -5,682 | -2,793 | -11,174 |
| Other Financing Activity | 29,981 | 19,403 | -7,274 | -7,564 | -165,983 |
| Financing Cash Flow | $18,480 | $10,820 | $-12,956 | $-10,357 | $-177,157 |
| Beginning Cash Position | 1,126 | 1,126 | 1,126 | 1,126 | 629 |
| End Cash Position | 2,202 | 1,101 | 764 | 1,278 | 1,126 |
| Net Cash Flow | $1,076 | $-25 | $-362 | $152 | $497 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,501 | 15,413 | 29,634 | 19,233 | -52,983 |
| Free Cash Flow | 18,501 | 15,413 | 29,634 | 19,233 | -52,983 |